STOCK TITAN

[Form 4] NEXGEL, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

NEXGEL (NXGL)

He sold 1,600 shares on 10/02/2025 at $2.5000 per share and 2,400 shares on 10/03/2025 at a weighted average price of $2.5497, with individual trades ranging from $2.5000 to $2.6100. After these transactions, he beneficially owned 371,692 shares.

NEXGEL (NXGL) CEO e amministratore Adam R. Levy ha divulgato vendite sul mercato aperto eseguite nell'ambito di un piano di negoziazione Rule 10b5-1.

Ha venduto 1.600 azioni il 02/10/2025 a 2,5000$ per azione e 2.400 azioni il 03/10/2025 a un prezzo medio ponderato di 2,5497$, con operazioni singole comprese tra 2,5000$ e 2,6100$. Dopo queste operazioni, detieneva beneficiariamente 371.692 azioni.

NEXGEL (NXGL) CEO y director Adam R. Levy divulgó ventas en el mercado abierto realizadas bajo un plan de negociación Rule 10b5-1.

Vendió 1.600 acciones el 02/10/2025 a $2.5000 por acción y 2.400 acciones el 03/10/2025 a un precio medio ponderado de $2.5497, con operaciones individuales que oscilaron entre $2.5000 y $2.6100. Después de estas transacciones, poseía de manera beneficiosa 371.692 acciones.

NEXGEL (NXGL)의 CEO 겸 이사인 Adam R. Levy가 Rule 10b5-1 트레이딩 플랜에 따라 실행된 공개시장 매도를 공개했습니다.

그는 2025년 10월 2일 주당 2.5000달러에 1,600주를 매도했고 2025년 10월 3일에는 주당 가중평균가 2.5497달러로 2,400주를 매도했으며 개별 거래는 2.5000달러에서 2.6100달러 사이였습니다. 이 거래 후 그는 유익하게도 371,692주를 보유하게 되었습니다.

NEXGEL (NXGL) CEO et administrateur Adam R. Levy a divulgué des ventes sur le marché libre effectuées dans le cadre d'un plan de négociation Rule 10b5-1.

Il a vendu 1 600 actions le 02/10/2025 à 2,5000$ par action et 2 400 actions le 03/10/2025 à un prix moyen pondéré de 2,5497$, les transactions individuelles allant de 2,5000$ à 2,6100$. Après ces transactions, il détenait beneficialment 371 692 actions.

NEXGEL (NXGL) CEO und Verwaltungsratsmitglied Adam R. Levy hat Offenmarktverkäufe bekannt gegeben, die unter einem Rule 10b5-1-Handelsplan durchgeführt wurden.

Er verkaufte am 02.10.2025 1.600 Aktien zu $2,5000 pro Aktie und am 03.10.2025 2.400 Aktien zu einem gewichteten Durchschnittspreis von $2,5497, wobei einzelne Trades zwischen $2,5000 und $2,6100 lagen. Nach diesen Transaktionen besaß er Beneficial Ownership von 371.692 Aktien.

NEXGEL (NXGL) أعلن الرئيس التنفيذي وعضو مجلس الإدارة آدم آر. ليڤي عن مبيعات في السوق المفتوح تمت بموجب خطة تداول Rule 10b5-1.

باع 1,600 سهم في 02/10/2025 بسعر 2,5000$ للسهم و2,400 سهم في 03/10/2025 بسعر متوسط موزون قدره 2,5497$، مع صفقات فردية تراوحت بين 2,5000$ و2,6100$. بعد هذه المعاملات، امتلك بشكلBeneficial 371,692 سهمًا.

NEXGEL (NXGL) 的首席执行官兼董事 Adam R. Levy 披露了在 Rule 10b5-1 交易计划下执行的场外市场销售。

他在 2025/10/02 以每股 2.5000 美元出售 1,600 股,在 2025/10/03 以加权平均价格 2.5497 美元出售 2,400 股,单笔交易价格区间为 2.5000-2.6100 美元。完成这些交易后,他受益所有权为 371,692 股。

Positive
  • None.
Negative
  • None.

NEXGEL (NXGL) CEO e amministratore Adam R. Levy ha divulgato vendite sul mercato aperto eseguite nell'ambito di un piano di negoziazione Rule 10b5-1.

Ha venduto 1.600 azioni il 02/10/2025 a 2,5000$ per azione e 2.400 azioni il 03/10/2025 a un prezzo medio ponderato di 2,5497$, con operazioni singole comprese tra 2,5000$ e 2,6100$. Dopo queste operazioni, detieneva beneficiariamente 371.692 azioni.

NEXGEL (NXGL) CEO y director Adam R. Levy divulgó ventas en el mercado abierto realizadas bajo un plan de negociación Rule 10b5-1.

Vendió 1.600 acciones el 02/10/2025 a $2.5000 por acción y 2.400 acciones el 03/10/2025 a un precio medio ponderado de $2.5497, con operaciones individuales que oscilaron entre $2.5000 y $2.6100. Después de estas transacciones, poseía de manera beneficiosa 371.692 acciones.

NEXGEL (NXGL)의 CEO 겸 이사인 Adam R. Levy가 Rule 10b5-1 트레이딩 플랜에 따라 실행된 공개시장 매도를 공개했습니다.

그는 2025년 10월 2일 주당 2.5000달러에 1,600주를 매도했고 2025년 10월 3일에는 주당 가중평균가 2.5497달러로 2,400주를 매도했으며 개별 거래는 2.5000달러에서 2.6100달러 사이였습니다. 이 거래 후 그는 유익하게도 371,692주를 보유하게 되었습니다.

NEXGEL (NXGL) CEO et administrateur Adam R. Levy a divulgué des ventes sur le marché libre effectuées dans le cadre d'un plan de négociation Rule 10b5-1.

Il a vendu 1 600 actions le 02/10/2025 à 2,5000$ par action et 2 400 actions le 03/10/2025 à un prix moyen pondéré de 2,5497$, les transactions individuelles allant de 2,5000$ à 2,6100$. Après ces transactions, il détenait beneficialment 371 692 actions.

NEXGEL (NXGL) CEO und Verwaltungsratsmitglied Adam R. Levy hat Offenmarktverkäufe bekannt gegeben, die unter einem Rule 10b5-1-Handelsplan durchgeführt wurden.

Er verkaufte am 02.10.2025 1.600 Aktien zu $2,5000 pro Aktie und am 03.10.2025 2.400 Aktien zu einem gewichteten Durchschnittspreis von $2,5497, wobei einzelne Trades zwischen $2,5000 und $2,6100 lagen. Nach diesen Transaktionen besaß er Beneficial Ownership von 371.692 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levy Adam R.

(Last) (First) (Middle)
C/O NEXGEL, INC.
2150 CABOT BLVD, WEST, SUITE B

(Street)
LANGHORNE PA 19047

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 S 1,600(1) D $2.5(2) 374,092 D
Common Stock 10/03/2025 S 2,400(1) D $2.5497(3) 371,692 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019
2. The Reporting Person sold all 1,600 shares of common stock in the open market at a price of $2.5000 per share.
3. Represents the weighted average of open market sale transactions ranging from $2.500 to $2.6100 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
/s/ Adam R. Levy 10/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NXGL report?

The CEO and director, Adam R. Levy, reported open‑market sales executed under a Rule 10b5‑1 trading plan.

How many NXGL shares did the CEO sell and on what dates?

He sold 1,600 shares on 10/02/2025 and 2,400 shares on 10/03/2025.

At what prices were the NXGL shares sold?

On 10/02/2025: $2.5000 per share. On 10/03/2025: $2.5497 weighted average, with trades ranging $2.5000–$2.6100.

How many NXGL shares does the CEO own after these sales?

Following the reported transactions, he beneficially owned 371,692 shares.

Were these NXGL insider sales part of a prearranged plan?

Yes. The filing states the sales were pursuant to a Rule 10b5‑1 plan instituted for tax planning purposes.

What was the ownership form for the reported NXGL shares?

The filing lists the holdings as Direct (D) ownership.
Nexgel Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Latest SEC Filings

NXGL Stock Data

19.04M
6.84M
15.54%
8.94%
0.46%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE